Objectives: to determine the diagnostic accuracy of different endometrial sampling tests for detecting endometrial carcinoma. Design: a systematic review and meta-analysis of studies of diagnostic accuracy. Eligibility criteria: We included published cross-sectional studies of women, of all ages, who had an endometrial sampling for preoperatively detecting endometrial cancer with verification using histopathology of hysterectomy specimens as the reference standard. We excluded case control and case series studies. Information sources: We searched the Cochrane library, MEDLINE/PubMed, CINAHL, Web of Science, and Scopus from the date of inception of the databases to December 31, 2022. We did not apply any restrictions on language or date of publication. We searched the references of included studies and other systematic reviews. Risk of bias: We extracted study data and assessed study quality using the revised quality assessment tool for diagnostic accuracy studies (QUADAS-2). Synthesis of results: We used bivariate diagnostic random-effects meta-analysis and presented the results in a summary receiver operating characteristic curve. We assessed the certainty of evidence as recommended by the GRADE approach. Results: Ten included studies, published between 1986 and 2020, recruited 1390 participants. Seven studies were low risk of bias in all domains and all studies had low applicability concerns. The most commonly studies index tests were Pipelle and conventional dilation and curettage. The sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio (95% confidence intervals), for Pipelle were 0.774 (0.565, 0.900), 0.985 (0.927, 0.997), 97.000 (14.000, 349.000), and 0.241 (0.101, 0.442) and for conventional dilation and curettage were 0.880 (0.281, 0.993), 0.984 (0.956, 0.995), 59.300 (14.200, 153.000), and 0.194 (0.007, 0.732); respectively. Conclusion: High certainty evidence indicates that pre-operative endometrial sampling particularly using Pipelle or conventional curettage is accurate in diagnosing endometrial cancer. Studies assessing other endometrial sampling tests were sparse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.